Literature DB >> 7593019

Heparin release from thermosensitive polymer coatings: in vivo studies.

A Gutowska1, Y H Bae, H Jacobs, F Mohammad, D Mix, J Feijen, S W Kim.   

Abstract

Biomer/poly(N-isopropylacrylamide)/[poly(NiPAAm)] thermosensitive polymer blends were prepared and their application as heparin-releasing polymer coatings for the prevention of surface-induced thrombosis was examined. The advantage of using poly (NiPAAm)-based coatings as heparin-releasing polymers is based on the unique temperature-dependent swelling of these materials. At room temperature, i.e., below the lower critical solution temperature (LCST) of poly (NiPAAm), the Biomer/(poly(NiPAAm) coatings are highly swollen. The high swelling enables fast loading of hydrophilic macromolecules (e.g., heparin) into the coating by a solution sorption technique. At a body temperature, i.e., above the LCST of poly (NiPAAm) the coatings are in a deswollen state and the absorbed macromolecules may be slowly released from a dense coating via a diffusion controlled mechanism. Biomer/poly(NiPAAm) coatings were obtained by blending and coprecipitation of the two linear polymers, Biomer and (poly(NiPAAm). The structure and water-swelling properties of the coatings were examined. Significant differences in water swelling at room temperature (RT) and 37 degrees C were observed as a result of the thermosensitivity of poly (NiPAAm). The surface structure of the coatings in dry and swollen states at RT and 37 degrees C was examined by scanning electron microscopy. Heparin was loaded into the coatings via a solution sorption at room temperature. Kinetic studies of heparin loading demonstrated that maximum loading was obtained within 1 h. The in vitro (37 degrees C) release profiles were characterized by a rapid initial release due to the squeezing effect of the collapsing polymer network, followed by a slower release phase controlled by heparin diffusion through the dense coating. The short-term antithrombogenicity of intravenous polyurethane catheters coated with heparin-releasing Biomer/poly(NiPAAm) thermosensitive coating was evaluated in a canine animal model. The results show that the heparin release from Biomer/poly(NiPAAm)-coated surfaces resulted in a significant reduction of thrombus formation on test surfaces in contact with venous blood as compared to control surfaces.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593019     DOI: 10.1002/jbm.820290705

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  8 in total

Review 1.  Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development.

Authors:  Daniel Radke; Wenkai Jia; Dhavan Sharma; Kemin Fena; Guifang Wang; Jeremy Goldman; Feng Zhao
Journal:  Adv Healthc Mater       Date:  2018-05-07       Impact factor: 9.933

2.  Dynamics of controlled release of heparin from swellable crosslinked starch microspheres.

Authors:  A K Bajpai; Smitha Bhanu
Journal:  J Mater Sci Mater Med       Date:  2007-05-05       Impact factor: 3.896

3.  Nitric Oxide Release for Improving Performance of Implantable Chemical Sensors - A Review.

Authors:  Kyoung Ha Cha; Xuewei Wang; Mark E Meyerhoff
Journal:  Appl Mater Today       Date:  2017-11-09

Review 4.  Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).

Authors:  Yaqi Wo; Elizabeth J Brisbois; Robert H Bartlett; Mark E Meyerhoff
Journal:  Biomater Sci       Date:  2016-05-26       Impact factor: 6.843

5.  Self-titrating anticoagulant nanocomplexes that restore homeostatic regulation of the coagulation cascade.

Authors:  Kevin Y Lin; Justin H Lo; Nikita Consul; Gabriel A Kwong; Sangeeta N Bhatia
Journal:  ACS Nano       Date:  2014-08-19       Impact factor: 15.881

6.  Ocular Biocompatibility of Poly-N-Isopropylacrylamide (pNIPAM).

Authors:  Luiz H Lima; Yael Morales; Thiago Cabral
Journal:  J Ophthalmol       Date:  2016-11-01       Impact factor: 1.909

7.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

8.  Nanoparticle-Mediated Angiotensin-(1-9) Drug Delivery for the Treatment of Cardiac Hypertrophy.

Authors:  Sabrina Sepúlveda-Rivas; Matías S Leal; Zully Pedrozo; Marcelo J Kogan; María Paz Ocaranza; Javier O Morales
Journal:  Pharmaceutics       Date:  2021-06-01       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.